LazyNews
NORMAL
Finance

Lilly announces three acquisitions to build infectious disease portfolio | Eli Lilly and Company - investor.lilly.com

The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.

Share:
Agreements with Curevo, LimmaTech Biologics and Vaccine Company address viral pathogens linked to long-term neurological and oncological risk, and bacterial pathogens that are difficult to prevent … [+8782 chars]

Community

Comments

Share your perspective. Thoughtful contributions make LazyNews useful.

0 comments

Log in to join the discussion.

Loading comments…